SAFETY AND EFFICACY OF MIPOMERSEN ADMINISTERED AS ADD-ON THERAPY IN PATIENTS WITH HYPERCHOLESTEROLEMIA AND HIGH CARDIOVASCULAR RISK

被引:13
|
作者
Cromwell, William C.
Thomas, Gregory S.
Boltje, Ingrid
Chin, Wai
Davidson, Michael
机构
[1] Presbyterian Cardiovasc Inst, Charlotte, NC USA
[2] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
关键词
D O I
10.1016/S0735-1097(11)60504-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E504 / E504
页数:1
相关论文
共 50 条
  • [1] Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia
    Reeskamp, Laurens F.
    Kastelein, John J. P.
    Moriarty, Patrick M.
    Duell, P. Barton
    Catapano, Alberico L.
    Santos, Raul D.
    Ballantyne, Christie M.
    ATHEROSCLEROSIS, 2019, 280 : 109 - 117
  • [2] A randomized, double-blind, placebo-controlled study to assess efficacy and safety of mipomersen as add-on therapy in heterozygous familial hypercholesterolemia patients with coronary artery disease
    Stein, E. A.
    Dufour, R.
    Gagne, C.
    Gaudet, D.
    East, C.
    Tribble, D.
    Donovan, J. M.
    Chin, W.
    Mcgowan, M.
    EUROPEAN HEART JOURNAL, 2010, 31 : 898 - 898
  • [3] Safety and efficacy of doxazosin as an add-on antihypertensive therapy
    Roccaforte, R.
    Fragasso, G.
    Spaladore, R.
    Calori, G.
    Arioli, F.
    Margonato, A.
    JOURNAL OF HYPERTENSION, 2006, 24 : S141 - S141
  • [4] Efficacy and safety of add on therapies in patients with hypercholesterolemia undergoing statin therapy
    Tomlinson, Brian
    Chan, Paul
    Zhang, Yuzhen
    Lam, Christopher Wai Kei
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (17) : 2137 - 2151
  • [5] Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patients
    Stein, Evan
    Bays, Harold
    Koren, Michael
    Bakker-Arkema, Rebecca
    Bisgaier, Charles
    JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (05) : 1212 - 1222
  • [6] The Safety and Efficacy of Pregabalin Add-on Therapy in Restless Legs Syndrome Patients
    Bae, Hyoeun
    Cho, Yong Won
    Kim, Keun Tae
    Allen, Richard P.
    Earley, Christopher J.
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [7] Cardiovascular risk according to add-on therapy in patients with type 2 diabetes
    Aagaard, D. T.
    Christiansen, M. Nielsen
    Mogensen, U. Madvig
    Bundgaard, J.
    Rorth, R.
    Madelaire, C.
    Fosbol, E. Loldrup
    Schou, M.
    Torp-Pedersen, C.
    Gislason, G.
    Kober, L.
    Kristensen, S. Lund
    EUROPEAN HEART JOURNAL, 2018, 39 : 492 - 492
  • [8] EFFICACY AND SAFETY OF MONTELUKAST ADD-ON THERAPY IN ALLERGIC RHINITIS
    Modgill, V.
    Badyal, D. K.
    Verghese, A.
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2010, 32 (09): : 669 - 674
  • [9] Efficacy and Safety of Alirocumab as Add-on Therapy in High-Cardiovascular-Risk Patients With Hypercholesterolemia Not Adequately Controlled With Atorvastatin (20 or 40 mg) or Rosuvastatin (10 or 20 mg): Design and Rationale of the ODYSSEY OPTIONS Studies
    Robinson, Jennifer G.
    Colhoun, Helen M.
    Bays, Harold E.
    Jones, Peter H.
    Du, Yunling
    Hanotin, Corinne
    Donahue, Stephen
    CLINICAL CARDIOLOGY, 2014, 37 (10) : 597 - 604
  • [10] Long-term efficacy and safety of perampanel as an add-on therapy in patients with epilepsy
    Arai, Yukika
    Inaji, Motoki
    Shimizu, Kazuhide
    Kondo, Shizukoto
    Hashimoto-Fujimoto, Satoka
    Kiyokawa, Juri
    Kawano, Yoshihisa
    Yamamoto, Shinji
    Maehara, Taketoshi
    EPILEPSY RESEARCH, 2024, 200